Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
European Journal of Immunology|March 31, 2000
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cellsC Pellat-Deceunynck, M P Mellerin, N Labarrière, et al.Cancer Immunology, Immunotherapy : CII|June 23, 2001
High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancementM C Pandolfino, N Labarrière, M H Tessier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cellsN Gervois, N Labarriere, S Le Guiner, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1997
Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcriptionN Labarriere, E Diez, M C Pandolfino, et al.European Journal of Immunology|March 4, 1998
Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatasesE Le Dréan, F Vély, L Olcese, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 23, 1998
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptideD Valmori, N Gervois, D Rimoldi, et al.The Journal of Experimental Medicine|March 1, 1996
A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V geneY Guilloux, S Lucas, V G Brichard, et al.Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responsesP André, M Groettrup, P Klenerman, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 20, 1998
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analoguesD Valmori, J F Fonteneau, C M Lizana, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1997
Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanomaP Romero, N Gervois, J Schneider, et al.Pageof 5